Sotac Pharmaceuticals Achieves Upper Circuit Limit Amid Surge in Trading Activity
Sotac Pharmaceuticals Ltd has experienced significant trading activity, reaching its upper circuit limit and demonstrating strong performance metrics. The stock's trading volume and turnover indicate healthy investor engagement, while a notable surge in delivery volume reflects increased participation and liquidity, reinforcing its market position.
Sotac Pharmaceuticals Ltd, a microcap player in the Pharmaceuticals & Drugs industry, has shown significant activity today, hitting its upper circuit limit with a high price of 128.85. The stock experienced a notable change of 6.1, translating to a percentage increase of 4.97. This performance outpaced the sector's average return of 1.01 and the Sensex's return of 0.34, highlighting Sotac's strong market position.The stock's trading volume reached 0.012 lakh, with a turnover of 0.015462 crore, indicating a healthy level of investor engagement. Notably, Sotac Pharmaceuticals is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its performance metrics.
Additionally, the delivery volume surged to 1.91 lakh on March 20, marking a remarkable increase of 579.49% compared to the 5-day average delivery volume. This uptick in trading activity reflects rising investor participation and liquidity, as the stock remains liquid enough for trades of Rs 0.01 crore based on 2% of the 5-day average traded value.
In summary, Sotac Pharmaceuticals Ltd has demonstrated robust performance today, characterized by its upper circuit limit achievement and strong trading metrics, reinforcing its position in the market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
